419 related articles for article (PubMed ID: 16344386)
1. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis.
Rissanen TT; Korpisalo P; Markkanen JE; Liimatainen T; Ordén MR; Kholová I; de Goede A; Heikura T; Gröhn OH; Ylä-Herttuala S
Circulation; 2005 Dec; 112(25):3937-46. PubMed ID: 16344386
[TBL] [Abstract][Full Text] [Related]
2. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
[TBL] [Abstract][Full Text] [Related]
3. Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy.
Korpisalo P; Hytönen JP; Laitinen JT; Laidinen S; Parviainen H; Karvinen H; Siponen J; Marjomäki V; Vajanto I; Rissanen TT; Ylä-Herttuala S
Eur Heart J; 2011 Jul; 32(13):1664-72. PubMed ID: 21138938
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.
Vajanto I; Rissanen TT; Rutanen J; Hiltunen MO; Tuomisto TT; Arve K; Närvänen O; Manninen H; Räsänen H; Hippeläinen M; Alhava E; Ylä-Herttuala S
J Gene Med; 2002; 4(4):371-80. PubMed ID: 12124979
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model.
Rissanen TT; Markkanen JE; Arve K; Rutanen J; Kettunen MI; Vajanto I; Jauhiainen S; Cashion L; Gruchala M; Närvänen O; Taipale P; Kauppinen RA; Rubanyi GM; Ylä-Herttuala S
FASEB J; 2003 Jan; 17(1):100-2. PubMed ID: 12475908
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits.
Hershey JC; Baskin EP; Corcoran HA; Bett A; Dougherty NM; Gilberto DB; Mao X; Thomas KA; Cook JJ
Heart Vessels; 2003 Jul; 18(3):142-9. PubMed ID: 12955430
[TBL] [Abstract][Full Text] [Related]
7. [Experimental study on treatment of acute limb ischemia with vascular endothelial growth factor-121 gene transfer].
Zheng ZH; Xu L; Fan XH
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2004 Mar; 18(2):142-5. PubMed ID: 15065417
[TBL] [Abstract][Full Text] [Related]
8. Effects of gene delivery on collateral development in chronic hypoperfusion: diverse effects of angiopoietin-1 versus vascular endothelial growth factor.
Zhou YF; Stabile E; Walker J; Shou M; Baffour R; Yu Z; Rott D; Yancopoulos GD; Rudge JS; Epstein SE
J Am Coll Cardiol; 2004 Aug; 44(4):897-903. PubMed ID: 15312878
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms.
Lähteenvuo JE; Lähteenvuo MT; Kivelä A; Rosenlew C; Falkevall A; Klar J; Heikura T; Rissanen TT; Vähäkangas E; Korpisalo P; Enholm B; Carmeliet P; Alitalo K; Eriksson U; Ylä-Herttuala S
Circulation; 2009 Feb; 119(6):845-56. PubMed ID: 19188502
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart.
Rutanen J; Rissanen TT; Markkanen JE; Gruchala M; Silvennoinen P; Kivelä A; Hedman A; Hedman M; Heikura T; Ordén MR; Stacker SA; Achen MG; Hartikainen J; Ylä-Herttuala S
Circulation; 2004 Mar; 109(8):1029-35. PubMed ID: 14967735
[TBL] [Abstract][Full Text] [Related]
11. The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice.
Huusko J; Merentie M; Dijkstra MH; Ryhänen MM; Karvinen H; Rissanen TT; Vanwildemeersch M; Hedman M; Lipponen J; Heinonen SE; Eriksson U; Shibuya M; Ylä-Herttuala S
Cardiovasc Res; 2010 Apr; 86(1):122-30. PubMed ID: 19955220
[TBL] [Abstract][Full Text] [Related]
12. Association between shear stress, angiogenesis, and VEGF in skeletal muscles in vivo.
Milkiewicz M; Brown MD; Egginton S; Hudlicka O
Microcirculation; 2001 Aug; 8(4):229-41. PubMed ID: 11528531
[TBL] [Abstract][Full Text] [Related]
13. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
[TBL] [Abstract][Full Text] [Related]
14. Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation.
Kupatt C; Hinkel R; Pfosser A; El-Aouni C; Wuchrer A; Fritz A; Globisch F; Thormann M; Horstkotte J; Lebherz C; Thein E; Banfi A; Boekstegers P
J Am Coll Cardiol; 2010 Jul; 56(5):414-22. PubMed ID: 20650363
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle.
Gounis MJ; Spiga MG; Graham RM; Wilson A; Haliko S; Lieber BB; Wakhloo AK; Webster KA
Gene Ther; 2005 May; 12(9):762-71. PubMed ID: 15772688
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of VEGF-A induces neovascularization and increased vascular leakage in rabbit eye after intravitreal adenoviral gene transfer.
Kinnunen K; Korpisalo P; Rissanen TT; Heikura T; Viita H; Uusitalo H; Ylä-Herttuala S
Acta Physiol (Oxf); 2006 Aug; 187(4):447-57. PubMed ID: 16866776
[TBL] [Abstract][Full Text] [Related]
17. Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia.
Dai Q; Huang J; Klitzman B; Dong C; Goldschmidt-Clermont PJ; March KL; Rokovich J; Johnstone B; Rebar EJ; Spratt SK; Case CC; Kontos CD; Annex BH
Circulation; 2004 Oct; 110(16):2467-75. PubMed ID: 15477407
[TBL] [Abstract][Full Text] [Related]
18. Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy.
Askari A; Unzek S; Goldman CK; Ellis SG; Thomas JD; DiCorleto PE; Topol EJ; Penn MS
J Am Coll Cardiol; 2004 May; 43(10):1908-14. PubMed ID: 15145120
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor mRNA and protein do not change in parallel during non-inflammatory skeletal muscle ischaemia in rat.
Milkiewicz M; Hudlicka O; Shiner R; Egginton S; Brown MD
J Physiol; 2006 Dec; 577(Pt 2):671-8. PubMed ID: 16990404
[TBL] [Abstract][Full Text] [Related]
20. An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia.
Xie D; Li Y; Reed EA; Odronic SI; Kontos CD; Annex BH
J Vasc Surg; 2006 Jul; 44(1):166-75. PubMed ID: 16753278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
